Determine Drug Off-Target Liability Early with MULTISCREEN™ 32-GPCR Safety Panel

View in browser

Follow us on Linkedin to receive more updates!

Determine Drug Off-Target Liability Early with

MULTISCREEN™ 32-GPCR Safety Panel

○ 32-GPCRs with well-defined CNS, cardiac, pulmonary and GI concerns

○ Address potential toxicity early to advance the best candidate to market

○ Available in endogenous cAMP or Calcium read-out with rapid turnaround

○ Publication-quality data in agonist and antagonist modes,

shared with control and raw data

Explore More!

MULTISCREEN™ 32-GPCR Off-Target Safety Panel

Learn More

Assay Performance

5-HT2B Calcium Assay

Catalog C1325-1

Alpha2A Calcium Assay

Catalog C1434-1a

What do our customers say?

"Multispan performs GPCR screening for us on a battery of 32 typical targets and off-target GPCRs in drug discovery. What is most impressive about their work product is that they determine functionality (agonist, partial agonist and antagonist) and potency from dose-response curves using multiplexing of assays. After comparison between vendors, we found Multispan to be the least expensive option and to provide the greatest value for the funds we have available. The post-assay customer interface is excellent in that they answer questions and provide relevant commentary as needed."

---Allen Reitz, Ph.D.

Chief Executive Officer, Fox Chase Therapeutics Discovery, Inc.

View More

info@multispaninc.com

www.multispaninc.com